The New IDH Inhibitor Is Approved

There's a new IDH inhibitor that was approved, all the two design up or Ivo side nib. The results in terms of duration of response and response rate seem to be equivalent or maybe a little bit better for the new drug. We still don't know how these patients would have done if they were originally treated with AZ-VAN which is again the standard of care in many places. So let's talk about maybe the next generation in clinical trials we're not going to talk about the AZ-Van IDH1 triplet so they're very promising but we will mention the AZ- VAN guilt-to-written-imp triplet.